Owlet vs Sanara Medtech
Owlet and Sanara Medtech are similar in size: $106m and $103m of revenue in their latest fiscal years. Owlet grew faster (37.1% against 19.0%). Sanara Medtech kept more of each dollar of sales as profit: a net margin of -36.4% against -36.6%.
| Latest fiscal year | OwletOWLT, 2025 | Sanara MedtechSMTI, 2025 |
|---|---|---|
| Revenue | $106m | $103m |
| Revenue growth | 37.1% | 19.0% |
| Net income | −$38.8m | −$37.6m |
| Operating margin | — | 7.1% |
| Net margin | -36.6% | -36.4% |
| Return on equity | — | -165.7% |
| Free cash flow | −$11.1m | $2.2m |
| Cash | $35.5m | $16.6m |
| Total debt | $20.0m | $46.9m |
| Debt to equity | — | 790.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 108 | 108 |
| Market value | $122m | $295m |
| Price vs our value range | — | — |
| Moat score | 25 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 6 sales | 0 buys, 0 sales |